ALEXANDRIA, Va. (Oct. 29, 2026) – The National Community Pharmacists Association today cheered a new rule released by the U.S. Department of Labor’s Employee Benefits Security Administration that requires pharmacy benefit managers and their affiliated brokers and consultants to disclose the fees and compensation they receive.
“The employers who pay PBMs to administer their health plans have been kept in the dark for many years when it comes to these fees and other forms of compensation. This new rule creates additional transparency for the first time,” said Ronna Hauser, PharmD, NCPA’s senior vice president of policy and pharmacy affairs.
The new rule (Improving Transparency into Pharmacy Benefit Manager Fee Disclosure), released today by the DOL, complements provisions included in the Consolidated Appropriations Act of 2026 and follows an executive order by President Donald Trump, “Lowering Drug Prices Once Again Putting Americans First.” NCPA strongly supported both measures. The rule ensures that employers can see for the first time how PBMs are actually paid. Employers and their fiduciaries can now use that information to negotiate contracts and seek lower prescription drug costs for workers and their families. The rule is projected by the DOL to lower prescription drug costs by as much as $22 billion over 10 years.
